Seeking Alpha / - 9 hours ago
Fedoronko has extensive expertise in oncology nursing, having worked at Karmanos for over two decades DETROIT, Sept. 15, 2025 /PRNewswire/ -- The Barbara Ann Karmanos Cancer Institute names Kathleen Fedoronko, MSN, RN, OCN, as the new chief nursing officer and vice president of Patient...
Seeking Alpha / - 10 hours ago
DALLAS, Sept. 15, 2025 /PRNewswire/ -- Fotona, a global leader in medical laser technologies for aesthetics, dermatology, surgery, gynecology, and dentistry, today announced the appointment of Daniel Larko as Vice President & General Manager for the United States and Canada. In this role,...
Seeking Alpha / - 10 hours ago
Nordecon AS kontserni kuuluv ettevõte Embach Ehitus OÜ ja Kaarsilla Kinnisvara OÜ sõlmisid töövõtulepingu kaubandushoone ehitamiseks Narvas, Kreenholmi 54A. Lepinguliste tööde kogumaksumuseks on 5,05 miljonit eurot ilma käibemaksuta ja hoone valmib 2026. aasta juulis.
Seeking Alpha / - 10 hours ago
Corbion hereby reports the transaction details related to its share buyback program announced on 1 September 2025.
Seeking Alpha / - 10 hours ago
Verkkokauppa.com updates its disclosure policy
Seeking Alpha / - 10 hours ago
Verkkokauppa.com päivittää tiedonantopolitiikkaansa
Seeking Alpha / - 10 hours ago
ATLANTA, Sept. 15, 2025 /PRNewswire/ -- Forbes Travel Guide ("FTG") — the only independent, global rating system for luxury hotels, restaurants, spas, ocean cruises and their restaurants — today announced the appointment of Tim Brooke-Webb as Chief Commercial Officer. A seasoned leader...
Seeking Alpha / - 10 hours ago
Leukemia publie les résultats du développement préclinique de la thérapie CAR-T GYA01 pour la leucémie myéloïde aiguë (LMA) et la leucémie lymphoblastique aiguë à cellules T (LLA-T) Gyala obtient un financement de trois millions d'euros auprès d'Invivo Partners, de Nara Capital et de CDTI...
Seeking Alpha / - 10 hours ago
Leukemia veröffentlicht präklinische Entwicklungsergebnisse der CAR-T-Therapie GYA01 für akute myeloische Leukämie (AML) und T-Zell-akute lymphoblastische Leukämie (T-ALL) Gyala sichert sich eine Finanzierung in Höhe von 3 Millionen Euro von Invivo Partners, Nara Capital und CDTI...
Seeking Alpha / - 10 hours ago
-Gyala Therapeutics presenta la primera terapia CAR-T de su clase, dirigida al receptor CD84, que ha demostrado una gran eficacia en estudios preclínicos contra tipos de leucemia difíciles de tratar Leukemia publica los resultados del desarrollo preclínico de la terapia CAR-T GYA01 para...
Seeking Alpha / - 10 hours ago
German photographer's portfolio covers life and loss at a Sudanese hospital WASHINGTON, Sept. 15, 2025 /PRNewswire/ -- This morning the International Women's Media Foundation announced Johanna Maria Fritz as the 2025 recipient of the IWMF Anja Niedringhaus Courage in Photojournalism...
Seeking Alpha / - 10 hours ago
Jason Wu Collection, Spring 2026 draws inspiration from art of Robert Rauschenberg, including iconic Purina checkerboard and Dog Chow packaging ST. LOUIS, Sept. 15, 2025 /PRNewswire/ -- Since 1926, Purina Dog Chow brand dog food has been a staple for millions of dog-loving families, and...
Seeking Alpha / - 10 hours ago
Leukemia publishes preclinical development results of CAR-T therapy GYA01 for acute myeloid leukemia (AML) and T-cell acute lymphoblastic leukemia (T-ALL) Gyala secures €3 million financing from Invivo Partners, Nara Capital and CDTI Innvierte to launch a Phase I trial in AML patients in...
Seeking Alpha / - 10 hours ago
"A Place of Promise" offers comfort to those navigating grief and seeking renewal ATLANTIC HIGHLANDS, N.J., Sept. 15, 2025 /PRNewswire/ -- Artist and author Marcie Shrewsbury Lopez's love story is far from conventional. She and her late husband, renowned magazine publisher Adrian B....
Seeking Alpha / - 10 hours ago
SUNNYVALE, Calif., Sept. 15, 2025 /PRNewswire/ -- Alpha Vision, a modern AI security platform that empowers organizations with intelligent agents and seamless automation, today announced its participation in Global Security Exchange (GSX) 2025, taking place September 29 - October 1 at...